Titre : Hymenolepis diminuta

Hymenolepis diminuta : Questions médicales fréquentes

Termes MeSH sélectionnés :

Informatics
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hymenolepis diminuta : Questions médicales les plus fréquentes", "headline": "Hymenolepis diminuta : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hymenolepis diminuta : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-03", "dateModified": "2025-04-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hymenolepis diminuta" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hymenolepis", "url": "https://questionsmedicales.fr/mesh/D006926", "about": { "@type": "MedicalCondition", "name": "Hymenolepis", "code": { "@type": "MedicalCode", "code": "D006926", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.050.500.500.736.215.454" } } }, "about": { "@type": "MedicalCondition", "name": "Hymenolepis diminuta", "alternateName": "Hymenolepis diminuta", "code": { "@type": "MedicalCode", "code": "D048190", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Derek M McKay", "url": "https://questionsmedicales.fr/author/Derek%20M%20McKay", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Pharmacology, Calvin, Joan, and Phoebe Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada." } }, { "@type": "Person", "name": "Anna Sulima-Celińska", "url": "https://questionsmedicales.fr/author/Anna%20Sulima-Celi%C5%84ska", "affiliation": { "@type": "Organization", "name": "Department of General Biology and Parasitology, Medical University of Warsaw, Warsaw, Poland." } }, { "@type": "Person", "name": "Daniel Młocicki", "url": "https://questionsmedicales.fr/author/Daniel%20M%C5%82ocicki", "affiliation": { "@type": "Organization", "name": "Department of General Biology and Parasitology, Medical University of Warsaw, Warsaw, Poland. daniel.mlocicki@wum.edu.pl." } }, { "@type": "Person", "name": "Uriel Koziol", "url": "https://questionsmedicales.fr/author/Uriel%20Koziol", "affiliation": { "@type": "Organization", "name": "Sección Biología Celular, Facultad de Ciencias, Universidad de la República, Montevideo 11400, Uruguay. Electronic address: ukoziol@gmail.com." } }, { "@type": "Person", "name": "Chaoqun Yao", "url": "https://questionsmedicales.fr/author/Chaoqun%20Yao", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences and One Health Center for Zoonoses and Tropical Veterinary Medicine, Ross Unive rsity School of Veterinary Medicine, P.O. Box 334, Basseterre, St. Kitts and Nevis." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Coronary Artery Computed Tomography Angiography for Preventing Cardio-Cerebrovascular Disease: Observational Cohort Study Using the Observational Health Data Sciences and Informatics' Common Data Model.", "datePublished": "2022-10-13", "url": "https://questionsmedicales.fr/article/36227638", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/41503" } }, { "@type": "ScholarlyArticle", "name": "The Memphis Pandemic Health Informatics System (MEMPHI-SYS)-Creating a Metropolitan COVID-19 Data Registry Linked Directly to Community Testing to Enhance Population Health Surveillance.", "datePublished": "2022-12-12", "url": "https://questionsmedicales.fr/article/36503600", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1017/dmp.2022.284" } }, { "@type": "ScholarlyArticle", "name": "Recognition motifs for importin 4 [(L)PPRS(G/P)P] and importin 5 [KP(K/Y)LV] binding, identified by bio-informatic simulation and experimental", "datePublished": "2022-10-26", "url": "https://questionsmedicales.fr/article/36382187", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.csbj.2022.10.015" } }, { "@type": "ScholarlyArticle", "name": "COVID-19 cluster surveillance using exposure data collected from routine contact tracing: The genomic validation of a novel informatics-based approach to outbreak detection in England.", "datePublished": "2024-04-25", "url": "https://questionsmedicales.fr/article/38662648", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pdig.0000485" } }, { "@type": "ScholarlyArticle", "name": "Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American Pathologists.", "datePublished": "2022-10-13", "url": "https://questionsmedicales.fr/article/36244574", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jmoldx.2022.09.007" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Animaux", "item": "https://questionsmedicales.fr/mesh/D000818" }, { "@type": "ListItem", "position": 4, "name": "Invertébrés", "item": "https://questionsmedicales.fr/mesh/D007448" }, { "@type": "ListItem", "position": 5, "name": "Helminthes", "item": "https://questionsmedicales.fr/mesh/D006376" }, { "@type": "ListItem", "position": 6, "name": "Plathelminthes", "item": "https://questionsmedicales.fr/mesh/D010986" }, { "@type": "ListItem", "position": 7, "name": "Cestoda", "item": "https://questionsmedicales.fr/mesh/D002589" }, { "@type": "ListItem", "position": 8, "name": "Hymenolepis", "item": "https://questionsmedicales.fr/mesh/D006926" }, { "@type": "ListItem", "position": 9, "name": "Hymenolepis diminuta", "item": "https://questionsmedicales.fr/mesh/D048190" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hymenolepis diminuta - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hymenolepis diminuta", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hymenolepis diminuta", "description": "Comment diagnostiquer une infection par Hymenolepis diminuta ?\nQuels tests sont utilisés pour confirmer l'infection ?\nQuels symptômes peuvent indiquer une infection ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?\nQuelle est la méthode de référence pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Informatics&page=44#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hymenolepis diminuta", "description": "Quels sont les symptômes courants d'une infection ?\nL'infection peut-elle être asymptomatique ?\nLes enfants sont-ils plus touchés par les symptômes ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes peuvent-ils varier selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Informatics&page=44#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hymenolepis diminuta", "description": "Comment prévenir l'infection par Hymenolepis diminuta ?\nLes animaux de compagnie peuvent-ils transmettre le parasite ?\nFaut-il éviter certains aliments pour prévenir l'infection ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes enfants doivent-ils être surveillés pour prévenir l'infection ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Informatics&page=44#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hymenolepis diminuta", "description": "Quel est le traitement standard pour Hymenolepis diminuta ?\nLes remèdes naturels sont-ils efficaces ?\nCombien de temps dure le traitement ?\nDes effets secondaires sont-ils associés au traitement ?\nLe traitement est-il efficace à 100 % ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Informatics&page=44#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hymenolepis diminuta", "description": "Quelles complications peuvent survenir avec l'infection ?\nL'infection peut-elle entraîner des problèmes de croissance chez les enfants ?\nY a-t-il un risque de réinfection ?\nLes infections chroniques peuvent-elles causer des complications ?\nLes complications sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Informatics&page=44#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hymenolepis diminuta", "description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLes enfants sont-ils plus vulnérables ?\nLe mode de vie urbain augmente-t-il le risque ?\nLes voyages dans des pays en développement sont-ils risqués ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Informatics&page=44#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Hymenolepis diminuta ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par l'examen des selles pour détecter les œufs du parasite." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer l'infection ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de selles répétés et éventuellement une endoscopie peuvent être utilisés." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une infection ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des nausées et des diarrhées." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sanguins ne sont généralement pas utiles pour diagnostiquer cette infection." } }, { "@type": "Question", "name": "Quelle est la méthode de référence pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La méthode de référence est l'examen microscopique des selles pour les œufs." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une infection ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleurs abdominales, diarrhée, fatigue et perte de poids." } }, { "@type": "Question", "name": "L'infection peut-elle être asymptomatique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses personnes peuvent être infectées sans présenter de symptômes." } }, { "@type": "Question", "name": "Les enfants sont-ils plus touchés par les symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent présenter des symptômes plus marqués en raison de leur immunité." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques à surveiller ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Surveillez les signes de déshydratation, surtout en cas de diarrhée sévère." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état de santé général." } }, { "@type": "Question", "name": "Comment prévenir l'infection par Hymenolepis diminuta ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une bonne hygiène, le lavage des mains et la cuisson des aliments." } }, { "@type": "Question", "name": "Les animaux de compagnie peuvent-ils transmettre le parasite ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les rongeurs peuvent être porteurs et transmettre le parasite aux humains." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments pour prévenir l'infection ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments crus ou mal cuits, surtout ceux susceptibles d'être contaminés." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones où l'hygiène est insuffisante peut augmenter le risque d'infection." } }, { "@type": "Question", "name": "Les enfants doivent-ils être surveillés pour prévenir l'infection ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants doivent être surveillés pour leur hygiène, surtout après avoir joué dehors." } }, { "@type": "Question", "name": "Quel est le traitement standard pour Hymenolepis diminuta ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard est l'administration de médicaments antiparasitaires comme le praziquantel." } }, { "@type": "Question", "name": "Les remèdes naturels sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de preuves solides que les remèdes naturels soient efficaces contre cette infection." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dure généralement quelques jours, selon la gravité de l'infection." } }, { "@type": "Question", "name": "Des effets secondaires sont-ils associés au traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des nausées ou des douleurs abdominales peuvent survenir." } }, { "@type": "Question", "name": "Le traitement est-il efficace à 100 % ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est généralement efficace, mais des suivis sont nécessaires pour éviter les récidives." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'infection ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles digestifs graves et des carences nutritionnelles." } }, { "@type": "Question", "name": "L'infection peut-elle entraîner des problèmes de croissance chez les enfants ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'infection peut affecter la croissance et le développement des enfants." } }, { "@type": "Question", "name": "Y a-t-il un risque de réinfection ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans mesures préventives, le risque de réinfection est élevé." } }, { "@type": "Question", "name": "Les infections chroniques peuvent-elles causer des complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections chroniques peuvent entraîner des complications plus graves." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes immunodéprimées." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent une mauvaise hygiène, le contact avec des rongeurs et des aliments contaminés." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées sont plus susceptibles de développer des infections graves." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus vulnérables en raison de leur système immunitaire en développement." } }, { "@type": "Question", "name": "Le mode de vie urbain augmente-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, vivre dans des zones urbaines avec des rongeurs peut augmenter le risque d'infection." } }, { "@type": "Question", "name": "Les voyages dans des pays en développement sont-ils risqués ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des pays avec de faibles normes d'hygiène augmentent le risque d'infection." } } ] } ] }

Sources (444 au total)

Coronary Artery Computed Tomography Angiography for Preventing Cardio-Cerebrovascular Disease: Observational Cohort Study Using the Observational Health Data Sciences and Informatics' Common Data Model.

Cardio-cerebrovascular diseases (CVDs) result in 17.5 million deaths annually worldwide, accounting for 46.2% of noncommunicable causes of death, and are the leading cause of death, followed by cancer... The objective of our study was to investigate the effectiveness of CCTA screening on CVD outcomes by using the Observational Health Data Sciences and Informatics' Observational Medical Outcomes Partne... Using electronic health record-based OMOP-CDM data, including health questionnaire responses, adults (aged 30-74 years) without a history of CVD were selected, and 5-year CVD outcomes were compared be... The 2-year and 5-year risk scores were compared as secondary outcomes between the two groups. In total, 8787 participants were included in both the target group and comparison group. No significant di... Although we could not confirm a significant difference in the preventive effects of CCTA screening for CVDs over a long period of 5 years, it may have a beneficial effect on risk score management over...

The Memphis Pandemic Health Informatics System (MEMPHI-SYS)-Creating a Metropolitan COVID-19 Data Registry Linked Directly to Community Testing to Enhance Population Health Surveillance.

The current coronavirus disease (COVID-19) pandemic has placed unprecedented strain on underfunded public health resources in the Southeastern United States. The Memphis, TN, metropolitan region has l...

Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American Pathologists.

In silico approaches for next-generation sequencing (NGS) data modeling have utility in the clinical laboratory as a tool for clinical assay validation. In silico NGS data can take a variety of forms,...

Houston Methodist cardiovascular learning health system (CVD-LHS) registry: Methods for development and implementation of an automated electronic medical record-based registry using an informatics framework approach.

To investigate the potential value and feasibility of creating a listing system-wide registry of patients with at-risk and established Atherosclerotic Cardiovascular Disease (ASCVD) within a large hea... We conducted a retrospective multi-center, cohort analysis of adult patients who were seen in the outpatient settings of a large healthcare system between June 2016 - December 2022 to create an EMR-ba... A real-time, programmatically deidentified, auto-updated EMR-based HM CVD-LHS registry was developed with ∼450 variables stored in multiple tables each containing information related to patient's demo... HM CVD-LHS registry database was developed successfully providing the listing registry of patients with established ASCVD and those at risk. This approach empowers knowledge inference and provides sup...

Leveraging Clinical Informatics and Data Science to Improve Care and Facilitate Research in Pediatric Acute Respiratory Distress Syndrome: From the Second Pediatric Acute Lung Injury Consensus Conference.

The use of electronic algorithms, clinical decision support systems, and other clinical informatics interventions is increasing in critical care. Pediatric acute respiratory distress syndrome (PARDS) ... MEDLINE (Ovid), Embase (Elsevier), and CINAHL Complete (EBSCOhost).... We included studies of pediatric or adult critically ill patients with or at risk of ARDS that examined automated screening tools, electronic algorithms, or clinical decision support systems.... Title/abstract review, full text review, and data extraction using a standardized data extraction form.... The Grading of Recommendations Assessment, Development and Evaluation approach was used to identify and summarize evidence and develop recommendations. Twenty-six studies were identified for full text... We present two clinical recommendations and three statements (two research one policy) for the use of electronic algorithms and clinical informatics tools for patients with PARDS based on a systematic...

Evaluating and Enhancing the Fitness-for-Purpose of Electronic Health Record Data: Qualitative Study on Current Practices and Pathway to an Automated Approach Within the Medical Informatics for Research and Care in University Medicine Consortium.

Leveraging electronic health record (EHR) data for clinical or research purposes heavily depends on data fitness. However, there is a lack of standardized frameworks to evaluate EHR data suitability, ... The study aims (1) to capture and discuss how MIRACUM DICs evaluate and enhance the fitness-for-purpose of observational health care data and examine the alignment with existing recommendations and (2... A qualitative approach was followed using an open-ended survey across DICs of 10 German university hospitals affiliated with MIRACUM. Data were analyzed using thematic analysis following an inductive ... All 10 MIRACUM DICs participated, with 17 participants revealing various approaches to assessing data fitness, including the 4-eyes principle and data consistency checks such as cross-system data valu... The study identifies gaps between current practices in MIRACUM DICs and existing recommendations, offering insights into the complexities of assessing and reporting clinical data fitness. Additionally...

Secondary use of health care data and left-over biosamples within the 'Medical Informatics Initiative' (MII): a quasi-randomized controlled evaluation of patient perceptions and preferences regarding the consent process.

Data collected during routine health care and ensuing analytical results bear the potential to provide valuable information to improve the overall health care of patients. However, little is known abo... We performed a quasi-randomized controlled trial and compared the method by which patients were informed either in the patient admission area following patient admission by the same staff member (Grou... Questionnaire data were obtained from 157 participants in Group A and 106 participants in Group B. Overall, participants in both groups were satisfied with their experienced process and with the way i... The willingness to support medical research by allowing the use of routine data and left-over samples seems to be widespread among patients. Information concerning this secondary data use may be given...